Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
The Aesthetic ShowThe Aesthetic Show
Not Confirmed
Not Confirmed
26-29 June, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Not Confirmed
Not Confirmed
29 June-01 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
The Aesthetic ShowThe Aesthetic Show
Industry Trade Show
Not Confirmed
26-29 June, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Industry Trade Show
Not Confirmed
29 June-01 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
03 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nasus-pharma-announces-the-publication-of-positive-clinical-results-from-its-phase-2-study-of-fmxin002-ns002-intranasal-epinephrine-powder-302471791.html
06 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nasus-pharma-announces-ground-breaking-five-years-stability-of-its-fmxin002-nasal-epinephrine-powder-for-severe-allergy-and-anaphylaxis-302215369.html
05 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nasus-pharma-announces-positive-clinical-results-of-recent-phase-2-study-with-fmxin002-intranasal-epinephrine-302005774.html
08 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nasus-pharma-announces-publication-of-its-positive-clinical-results-with-fmxin002-intranasal-powder-epinephrine-spray-in-the-journal-of-allergy-and-clinical-immunology-in-practice-301895373.html
24 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/nasus-pharma-announces-clinical-data-demonstrating-efficacy-of-taffix--intranasal-antiviral-protection-against-common-cold-and-upper-respiratory-infection-301431485.html
17 Aug 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/taffix-r-recupera-la-aprobacion-de-comercializacion-en-espana-876429672.html
ABOUT THIS PAGE